Aetna (AET) is expected to report Q2 earnings Tuesday, July 27 after market close with a conference call scheduled for 8:30 am ET Wednesday, July 28.
Analysts are looking for EPS of 74c on revenue of $8.49B. The consensus range is 64c-84c for EPS, and $8.35B-$8.66B for revenue, according to First Call. On June 17, Aetna said it sees Q2 EPS greater than current analysts’ consensus estimate of 68c. Possible contributions to the insurers Q2 EPS may come from lower medical costs.
On July 12, Aetna was downgraded to Neutral from Buy at UBS based on concerns that reform-mandated benefits will increase costs and delay margin expansion. The firm reduced its target to $30 from $38 for the shares. On July 12, Aetna was initiated with a Hold and $29 price target at Citigroup.